drugset / Trial / NCT00635401

A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking

NCT00635401

Phase 2 Completed 30 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of varenicline in Japanese smokers. Efficacy is evaluated by continuous quit rate and withdrawal symptoms of smokers. Safety is evaluated by adverse events, laboratory tests, and other safety tests.

Timeline

Start
2004-05
Primary completion
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 0.5 mg

Indications

No indication recorded.